NCT01445938View on ClinicalTrials.gov

Anti-parasitic Activity and Safety Assessment of SAR97276A in Children With Uncomplicated Malaria

PHASE2TerminatedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

January 31, 2012

Study Completion Date

January 31, 2012

Conditions
Malaria
Interventions
DRUG

SAR97276A

"Pharmaceutical form:solution for injection~Route of administration: intramuscular"

DRUG

arthemeter + lumefantrine (ACTs)

"Pharmaceutical form:tablet~Route of administration: oral"

Trial Locations (4)

Unknown

Investigational Site Number 204001, Cotonou

Investigational Site Number 854001, Ouagadougou

Investigational Site Number 266001, Libreville

Investigational Site Number 404001, Kisumu

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY